We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+26.4%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$9.23B
AUM Growth
+$1.45B
(+19%)
Cap. Flow
-$223M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
19.32%
Holding
1,206
New
212
Increased
430
Reduced
347
Closed
177
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$62.9M |
| 2 |
AutoZone
AZO
|
+$61.2M |
| 3 |
Hershey
HSY
|
+$46.1M |
| 4 |
Intercontinental Exchange
ICE
|
+$41.2M |
| 5 |
General Motors
GM
|
+$40M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$104M |
| 2 |
Biogen
BIIB
|
+$89.3M |
| 3 |
Coca-Cola
KO
|
+$66.3M |
| 4 |
AbbVie
ABBV
|
+$59.1M |
| 5 |
American Homes 4 Rent
AMH
|
+$44.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.96% |
| 2 | Healthcare | 15.83% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 12.53% |
| 5 | Industrials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
TG Therapeutics
TGTX
$8.58B
| $466K | 0.01% |
23,900
-1,501
| -6% | -$24.2K |
|
|
AGEN
802
Agenus
AGEN
$253M
| $462K | 0.01% |
5,984
-15
| -0.3% | -$898 |
|
803
United Fire Group
UFCS
$1.34B
| $457K | ﹤0.01% |
16,488
-8,924
| -35% | -$252K |
|
|
CNR
804
Core Natural Resources Inc
CNR
$4.05B
| $457K | ﹤0.01% |
+90,196
| New | +$562K |
|
805
Autoliv
ALV
$8.91B
| $456K | ﹤0.01% |
+7,069
| New | +$425K |
|
|
ZNGA
806
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $456K | ﹤0.01% |
47,800
-205,171
| -81% | -$1.68M |
|
|
GNTY
807
DELISTED
Guaranty Bancshares
GNTY
| $454K | ﹤0.01% |
19,309
+8,961
| +87% | +$202K |
|
|
LJPC
808
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $454K | ﹤0.01% |
106,646
+26,428
| +33% | +$161K |
|
809
Northwest Natural Holdings
NWN
$2.2B
| $453K | ﹤0.01% |
8,113
-7,454
| -48% | -$455K |
|
810
Alector
ALEC
$168M
| $452K | ﹤0.01% |
+18,480
| New | +$510K |
|
|
AIMT
811
DELISTED
Aimmune Therapeutics
AIMT
| $448K | ﹤0.01% |
+26,840
| New | +$456K |
|
812
Haverty Furniture Companies
HVT
$410M
| $446K | ﹤0.01% |
27,874
-43,747
| -61% | -$639K |
|
813
United Natural Foods
UNFI
$3.02B
| $442K | ﹤0.01% |
+24,260
| New | +$364K |
|
|
INVX
814
Innovex International
INVX
$1.82B
| $439K | ﹤0.01% |
14,750
-164,672
| -92% | -$5.06M |
|
815
Lexicon Pharmaceuticals
LXRX
$977M
| $438K | ﹤0.01% |
219,311
-186,827
| -46% | -$366K |
|
816
Belden
BDC
$4.08B
| $434K | ﹤0.01% |
+13,337
| New | +$444K |
|
817
Sterling Infrastructure
STRL
$17.4B
| $431K | ﹤0.01% |
41,207
-202,738
| -83% | -$1.87M |
|
818
OP Bancorp
OPBK
$236M
| $426K | ﹤0.01% |
61,720
+21,972
| +55% | +$148K |
|
819
Harmonic Inc
HLIT
$1.16B
| $419K | ﹤0.01% |
88,173
-221,982
| -72% | -$1.24M |
|
820
VYNE Therapeutics
VYNE
$19.1M
| $411K | ﹤0.01% |
66
+52
| +371% | +$352K |
|
|
HALL
821
DELISTED
Hallmark Financial Services, Inc.
HALL
| $411K | ﹤0.01% |
11,765
+24
| +0.2% | +$804 |
|
|
IVC
822
DELISTED
Invacare Corporation
IVC
| $410K | ﹤0.01% |
64,305
+16,179
| +34% | +$108K |
|
|
PROS
823
DELISTED
ProSight Global, Inc.
PROS
| $408K | ﹤0.01% |
+45,866
| New | +$417K |
|
824
Ardelyx
ARDX
$1.25B
| $406K | ﹤0.01% |
58,736
| – | – |
|
825
Bright Horizons
BFAM
$4.24B
| $405K | ﹤0.01% |
3,454
+1,424
| +70% | +$163K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2020 Portfolio in Review
As of Q2 2020, Jacobs Levy Equity Management held 1,206 positions worth $9.23B, up 19% from $7.78B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jacobs Levy Equity Management's Q2 2020 filing shows 212 new, 430 increased, 347 reduced and 177 closed positions. Its largest new stake was Lowe's Companies: 259,943 shares worth $35.1M. The largest sale was Mastercard, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Jacobs Levy Equity Management's largest Q2 2020 buy was Lowe's Companies: 259,943 shares worth $35.1M.
- Jacobs Levy Equity Management added most to Qualcomm in Q2 2020, an estimated $62.9M increase.
- Jacobs Levy Equity Management's biggest Q2 2020 reduction was Mastercard, cutting an estimated $104M.
- Jacobs Levy Equity Management fully exited Sysco in Q2 2020, selling an estimated $36.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 19% of its $9.23B portfolio in Q2 2020.
- Jacobs Levy Equity Management opened 212 new positions and closed 177 in Q2 2020.
- Jacobs Levy Equity Management's portfolio value rose 19% quarter-over-quarter to $9.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2020, filed 17 Aug 2020.